Ranbaxy weighs options after Lipitor patent ruling (Reuters via Yahoo! Asia News)
Ranbaxy weighs options after Lipitor patent ruling (Reuters via Yahoo! Asia News)
NEW YORK, Aug 2 (Reuters) – Generic drugmaker Ranbaxy Laboratories said it was “evaluating” its options after a U.S. appeals court earlier on Wednesday affirmed the validity of the basic patent on Pfizer Inc.’s Lipitor cholesterol fighter.